Avacta Announces FDA Approval of its Investigational New Drug (IND) Application for AVA6000
Avacta Group plc a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer and pre|CISION platforms, is…
Read More...
Read More...
